All stock lists
CervoMed Inc. (NASDAQ:CRVO)
US · Delayed Price · Currency is USD
Also listed: DFFNHealthcare · Biotechnology
1.77+0.40 (+29.20%)
Market cap
$26.8M
Insider Score
Health Score
Analyst consensus
Listed since
May 23, 2008
Website
Insider Score
––Not scored
CRVO Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
CRVO analyst forecast
CRVO analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
CRVO 12-month price target
No published price targets in the last 12 months.
Best analysts covering CRVO
- D. Boral Capital23%success rate · -33.4% avg return · 13 calls
- Canaccord Genuity20%success rate · +18.6% avg return · 5 calls
- Chardan Capital0%success rate · -47.4% avg return · 5 calls
- HC Wainwright & Co.0%success rate · -80.3% avg return · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CRVO analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-10-05 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-08-12 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-08-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-07-15 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-07-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-07-09 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-04-23 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2026-04-22 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2026-04-08 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2026-03-19 |
| — | Roth Capital | Buy | — | — | Reiterated | 2026-03-18 |
| — | Chardan Capital | Buy | — | — | Reiterated | 2026-03-18 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2026-03-16 |
| — | Chardan Capital | Buy | — | — | Reiterated | 2026-03-05 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2026-03-04 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2026-02-18 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-12-18 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2025-12-05 |
| — | D. Boral Capital | Buy | — | — | Reiterated | 2025-12-02 |
CRVO earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-13 | -0.79 | -0.88 | $91K | $7K |
| 2026-05-18 | -0.90 | -0.86 | $71K | $0 |
| 2026-08-10 | -0.87 | -0.64 | $50K | $0 |
| 2026-11-09 | -0.47 | -0.39 | $50K | $0 |
| 2027-03-12Upcoming | -0.65 | — | $83K | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.